Skip to content

Elation™ 00884450398944Recalls & reported problems

Merit Medical Systems, Inc. · Class 2

Adverse event reports
1
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884450398944), received between Aug 27, 2024 and Aug 27, 2024 — classified as 1 death.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • DeathAug 27, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE ACCOUNT ALLEGES THAT DURING A ROUTINE TRACHEOBRONCHIAL POLYURETHANE STENT FOLLOW-UP APPOINTMENT FOR A FEMALE CANCER PATIENT CURRENTLY RECEIVING PALLIATIVE CARE DUE TO CANCER, THE PHYSICIAN NOTED SOME NARROWING AND WITH MINOR GRANULATED TISSUE PRESENT AT THE STENT SITE. THE STENT WAS PLACED FOR A CANCER-RELATED STRICTURE APPROXIMATELY TWO WEEKS AGO WITHOUT ISSUE. THE PATIENT RECEIVED ONE TREATMENT OF RADIATION THERAPY POST-STENT IMPLANT ON AN UNKNOWN DATE. THE INTERVENTIONAL PULMONOLOGIST RECOMMENDED REMOVING THE EXISTING STENT AND UPSIZING IT TO A LARGER STENT FOR THE PATIENT. DURING THE STENT REMOVAL PROCEDURE, A PULMONARY BALLOON DILATATION CATHETER WAS USED TO DILATE THE INNER DIAMETER OF THE STENT UNDER FLUOROSCOPIC GUIDANCE AND AN ATTEMPT TO REMOVE THE STENT WITH A PAIR OF RAPTOR FORCEPS WAS INITIATED SUCCESSFULLY. THE ACTUAL STENT REMOVAL PROCESS WAS UNREMARKABLE. SOON AFTER THE STENT WAS REMOVED BLEEDING WAS NOTED AT THE STENT SITE. SUCTION WAS ATTEMPTED BUT UNSUCCESSFUL IN CONTROLLING THE HEMORRHAGING. THE PATIENT BECAME HEMODYNAMICALLY UNSTABLE AND A CODE BLUE WAS INITIATED. LIFE-SAVING PROTOCOLS WERE ATTEMPTED FOR THIS PATIENT WITH NO SUCCESS. THE PATIENT DIED IN THE

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 20077133 ↗

Other Bronchoscope accessory devices

All Bronchoscope accessory devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.